Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

dard of care."

The Phase 3 study was designed to compare the safety and efficacy of motavizumab with that of Synagis, which was first launched by MedImmune in 1998, in reducing serious RSV disease in high-risk infants in the inpatient and outpatient settings. As defined in the study, infants who are at high risk for RSV include those who were born at 35 weeks gestation or less as well as those who have chronic lung disease (CLD) due to being born prematurely. The primary endpoint was to assess the incidence of RSV hospitalizations with motavizumab compared to Synagis. Motavizumab met the primary endpoint, demonstrating non-inferiority to Synagis with 26 percent fewer RSV hospitalizations in motavizumab-treated infants. The overall RSV attack rate was low in both treatment groups: 1.4 percent for infants who received motavizumab, compared with 1.9 percent for those who received Synagis [RR: 0.740, 95 percent CI: (0.503, 1.083)]. The p-value for non-inferiority was p<0.01, demonstrating a significant finding.

Analysis of the data also showed that motavizumab reduced the incidence of RSV-specific medically attended outpatient LRIs (the study's RSV-related secondary endpoint) by approximately 50 percent compared with Synagis. The overall RSV-specific medically attended LRI rate was 2.0 percent for infants who received motavizumab compared with 3.9 percent for those who received Synagis (p<0.01). There were no significant differences in other non-RSV- specific endpoints.

"I am very pleased with the study results for motavizumab," said Xavier Carbonell, M.D., Ph.D., lead study author, chairman of neonatology, Barcelona Hospital Clinic, and vice president, Spanish Neonatal Society. "As a practicing neonatologist, I look forward to the potential to use this next- generation antibody to help reduce RSV-related hospitalizations and LRIs in the outpatient setting."

Data from this trial demonstrate that both study drugs were well tolerated. The incid
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/d85hx9/global_rapid ) has announced the ... Market - Applications and Technologies" report to their ... Kits, estimated at US$19.4 billion in 2014, forecast at ... a CAGR of 5.7% between 2014 and 2020 to ... The global market for Rapid Medical Diagnostic Kits (MDKs) ...
(Date:5/27/2015)... , May 27, 2015  With Freudenberg ... a unique service: machined seals from the ... The seals, that have the same material ... original Freudenberg-NOK series products, can be made-to-order ... cost-effective small production runs. The agenda is ...
(Date:5/27/2015)... , LONDON and ... - http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over ... - Around 400,000 Indonesians die annually due to ... - Three-fourths of 6.5 million vehicles in ... test Indonesia is ...
Breaking Medicine Technology:Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4Xpress Service from Freudenberg-NOK Quickly Delivers Made-to-Order Sealing Solutions to Customers 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
(Date:5/27/2015)... 27, 2015 While hair transplantation has ... a new pilot study conducted by a physician member ... has found hair follicle grafting can help treat patients ... partially funded by ISHRS, which offers research grants for ... restoration. , In the past decade, numerous scientific ...
(Date:5/27/2015)... 2015 NOVAtime Technology, Inc. ( ... solutions for enterprise organizations, announced today that SanMar ... automate its time, attendance and point tracking processes ... the United States. , Family-owned since 1971, ... 21 retail, private label, and mill brands. SanMar ...
(Date:5/27/2015)... ABILENE, Texas (PRWEB) May 27, 2015 ... addition of three FDA-approved dermal filler treatments in Abilene, ... designed to reduce the appearance of glabellar lines, better ... lines. Belotero Balance® is designed to treat smoker’s ... mouth to the chin, while Radiesse® improves the appearance ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
(Date:5/27/2015)... San Francisco, CA (PRWEB) May 27, 2015 ... into a total communication environment where the message is not ... face, a toy, drawing, or virtually any motivating image. This ... iPad has to offer. , Now, using InnerVoice ... same messages can be sent to a learner remotely for ...
Breaking Medicine News(10 mins):Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 2Health News:New Research Finds Hair Grafting a Promising Therapy for Chronic Leg Ulcers - International Society of Hair Restoration Surgery Awards Research Grant 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:The MedSpa at Hendrick Introduces Xeomin®, Belotero Balance® and Radiesse® Injectables 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4
... BEND, Ore., Oct. 20 Bend Research Inc. ... expertise and,technologies to outside firms in the pharmaceutical ... 23-year collaboration with Pfizer but,will also be free ... jointly by the two firms., These technologies ...
... Study finds increased risk of death, heart attacks , , MONDAY, ... doubts about using beta blockers to reduce the risks of ... before non-cardiac surgery was 10 times higher in the 30 ... drugs (2.52 percent vs. 0.25 percent), according to a report ...
... Oct. 20 /PRNewswire/ - Ocean Nutrition Canada Limited ... oil to the food and,dietary supplement industries is ... investment secures ONC,s position as the largest,fish oil ... their world class molecular distillation plant in,Mulgrave, Nova ...
... Insulet Corporation,(Nasdaq: PODD ), the leader in patch ... the appointment of Sally W.,Crawford to its board of ... chief operating officer of Healthsource Inc., a managed care,organization. ... venture,capital firm in life sciences, on Insulet,s board of ...
... treatment in these patients , , MONDAY, Oct. 20 (HealthDay ... risk of fractures, particularly of potentially crippling breaks in ... study of more than 16,000 heart disease patients treated ... a more than fourfold higher incidence of fractures among ...
... Offer ,The Prevention Plan(TM), Health Management Program to ... ... U.S. Preventive Medicine(R), the leader,in disease prevention, today announced that the ... golf tournaments to amateur golfers in the Metro Atlanta area,will offer ...
Cached Medicine News:Health News:Bend Research Offers Broad Access to Drug-Delivery Solutions 2Health News:Questions Continue About Using Beta Blockers Before Surgery 2Health News:Questions Continue About Using Beta Blockers Before Surgery 3Health News:Ocean Nutrition Canada Limited Secures Their Position as the Largest Omega-3 EPA/DHA Ingredient Supplier in the World 2Health News:Sally W. Crawford Joins Insulet's Board of Directors 2Health News:Sally W. Crawford Joins Insulet's Board of Directors 3Health News:Sally W. Crawford Joins Insulet's Board of Directors 4Health News:Heart Failure Raises Risk of Fractures 2Health News:Heart Failure Raises Risk of Fractures 3Health News:U.S. Preventive Medicine(R) Tees Up with Amateur Golf Association 2
For the quantitative in vitro determination of Magnesium in serum, plasma and urine...
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: